James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 87,110 shares at $2.05 ($101K) on 2024-06-26, disclosed to the SEC on 2024-06-28.
Open-market sale of $101k CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 37,890 | $0 | 0.0% |
| 2 | $2.05 | 24,610 | $50K | 50.0% |
| 3 | $2.05 | 24,610 | $50K | 50.0% |
| Total | $1.16 avg | 87,110 | $101K | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |
| CKPT | SELL | 2024-02-02 | $24K | — | Filing → |